Breaking
$6 Billion in Suspected SNAP Fraud Stopped by USDA Task Force✦54% of BBC News Audiences Rate It Impartial as Charter Review Looms✦Sexual Assaults Up 650% in Ceuta, Bladed-Weapon Incidents Rise from 23 to 268✦336 Police Contacts, 8 Deportation Attempts: Germany's 22-Year Removal Failure✦€213.7 Million: EPPO Indicts Suspect in Bulgarian Railway Fraud✦19 Witnesses, Zero Racism Charges: France Drops Anti-White Motive in Perotto Murder✦$6 Billion in Suspected SNAP Fraud Stopped by USDA Task Force✦54% of BBC News Audiences Rate It Impartial as Charter Review Looms✦Sexual Assaults Up 650% in Ceuta, Bladed-Weapon Incidents Rise from 23 to 268✦336 Police Contacts, 8 Deportation Attempts: Germany's 22-Year Removal Failure✦€213.7 Million: EPPO Indicts Suspect in Bulgarian Railway Fraud✦19 Witnesses, Zero Racism Charges: France Drops Anti-White Motive in Perotto Murder✦
Sunday, 22 November 2026Est. 2026

FRISIAN NEWS

The numbers behind the news

Why the CDC Finally Questioned a 30-Year Vaccine Rule
Infrastructure

Why the CDC Finally Questioned a 30-Year Vaccine Rule

May 24, 2026 · Frisian News

The CDC's vaccine advisory committee debated universal immunization policy for the first time in over three decades, revealing how entrenched public health recommendations become immune to scrutiny.

English

In December 2025, the CDC's Advisory Committee on Immunization Practices held a rare debate. The question was simple but radical: should America still recommend one vaccine for every child without exception? The recommendation had stood for over 30 years, unchanged by the same committee tasked with reviewing it.

When a policy lives that long without serious debate, it stops being policy and becomes dogma. No one asks why anymore. Many new doctors learn it as fact. Many parents assume it is necessary. Many journalists repeat it as gospel. The original reasons for the rule fade from memory, replaced by the weight of tradition. The CDC did not revisit this one through intellectual courage but because outside pressure finally made silence impossible.

Who benefits from unchanging policy? Drug manufacturers benefit from stable demand. Health bureaucrats benefit from simplicity, which looks clean in reports and avoids difficult conversations. State health departments benefit from one-size-fits-all rules that need no local judgment. The people who pay most attention are the ones with the least incentive to ask hard questions.

The committee's debate itself mattered less than the fact that debate happened at all. The two worldviews on display were not new: one treats universal recommendations as the safest path, the other asks whether universal means right. What changed was that the second view got a seat at the table. That should have happened years ago.

Institutions resist re-examination of old decisions. Admitting that a 30-year rule might need change means admitting that no one questioned it sooner. It means asking uncomfortable questions about how many other policies sit unchallenged for decades. The CDC still recommends caution on such matters. But once a committee agrees to debate, the real work begins.


Published May 24, 2026 · Frisian News